Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome-Reference-Cited by-同舟云学术

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome

Published:2015-01-14 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Madan Vikas,Kanojia Deepika,Li Jia,Okamoto Ryoko,Sato-Otsubo Aiko,Kohlmann Alexander,Sanada Masashi,Grossmann Vera,Sundaresan Janani,Shiraishi Yuichi,Miyano Satoru,Thol Felicitas,Ganser Arnold,Yang Henry,Haferlach Torsten,Ogawa Seishi,Koeffler H. Phillip

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms7042.pdf

Reference70 articles.

1. Hofmann, W. K. & Koeffler, H. P. Myelodysplastic syndrome. Annu. Rev. Med. 56, 1–16 (2005).

2. Greenberg, P. L. The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic features. J. Natl Compr, Canc. Netw. 11, 877–884 quiz 885 (2013).

3. Ma, X. Epidemiology of myelodysplastic syndromes. Am. J. Med. 125, S2–S5 (2012).

4. Tefferi, A. & Vardiman, J. W. Myelodysplastic syndromes. New Engl. J. Med. 361, 1872–1885 (2009).

5. Sekeres, M. A. & Bejanyan, N. The revolution of myelodysplastic syndromes. Ther. Adv. Hematol. 2, 33–43 (2011).

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review;Diagnostic Pathology;2024-09-07

2. Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing;Pharmacology & Therapeutics;2024-09

3. Role of U11/U12 minor spliceosome geneZCRB1in Ciliogenesis and WNT Signaling;2024-08-10

4. RNA binding protein‐directed control of leukemic stem cell evolution and function;HemaSphere;2024-08

5. Molecular impact of mutations in RNA splicing factors in cancer;Molecular Cell;2024-08